Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)
China · Delayed Price · Currency is CNY 10.93
-0.17 (-1.53%)
Sep 10, 2026, 2:40 PM CST
SHE:002923 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,337 | 1,176 | 1,182 | 1,292 | 1,372 | 1,190 |
Revenue Growth | 17.99% | -0.51% | -8.48% | -5.85% | 15.32% | -5.01% |
Gross Profit Gross Profit Growth | 523.18 | 411.75 | 490.47 | 606.86 | 735.92 | 711.09 |
Operating Income Operating Income Growth | 55.49 | -26.57 | 39.01 | 71.43 | 166.02 | 138.49 |
Net Income Net Income Growth | 13.47 | -63.47 | 39.88 | 66.9 | 155.48 | 139.77 |
Earnings Per Share EPS Growth | 0.04 | -0.19 | 0.12 | 0.20 | 0.46 | 0.41 |
EPS Growth | - | - | -40.00% | -56.52% | 11.03% | 1.89% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Chemical Pharmaceutical Manufacturing Chemical Pharmaceutical Manufacturing Growth | 649.46 | 683.29 | 784.68 | 860.81 | 766.64 |
Manufacturing of Active Pharmaceutical Ingredients Manufacturing of Active Pharmaceutical Ingredients Growth | 508.82 | 493.54 | 497.15 | 502.41 | 421.31 |
Unallocated Other Operations Unallocated Other Operations Growth | 18.08 | 5.53 | 10.06 | 9.01 | 1.98 |
Total Total Growth | 1,176 | 1,182 | 1,292 | 1,372 | 1,190 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 308.06 | 256.22 | 206.58 | 213.91 | 221.09 | 250.39 |
Total Debt Total Debt Growth | 362.84 | 532.32 | 500.54 | 572.82 | 468.43 | 286.61 |
Net Cash (Debt) Net Cash Growth | -54.77 | -276.1 | -293.96 | -358.91 | -247.33 | -36.22 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.16 | -0.83 | -0.88 | -1.07 | -0.73 | -0.11 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 167.67 | 104.41 | 211.19 | 172.68 | 135.01 | 205.91 |
Capital Expenditures CapEx Growth | -17.33 | -17.96 | -81.25 | -174.53 | -251.75 | -376.48 |
Free Cash Flow Free Cash Flow Growth | 150.34 | 86.44 | 129.94 | -1.85 | -116.75 | -170.58 |
Free Cash Flow Growth | 43.41% | -33.47% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 39.13% | 35.00% | 41.48% | 46.98% | 53.63% | 59.76% |
Operating Margin | 4.15% | -2.26% | 3.30% | 5.53% | 12.10% | 11.64% |
Pretax Margin | 1.96% | -5.07% | 3.61% | 6.66% | 13.19% | 12.75% |
Profit Margin | 1.01% | -5.40% | 3.37% | 5.18% | 11.33% | 11.75% |
FCF Margin | 11.24% | 7.35% | 10.99% | -0.14% | -8.51% | -14.34% |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.150 | 0.200 | 0.250 | 0.220 |
Dividend Per Share Growth | -25.00% | -20.00% | 13.74% | 0% |
Dividend Yield | 1.59% | 1.67% | 2.10% | 1.75% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 279.60 | - | 80.11 | 61.77 | 26.93 | 32.57 |
P/FCF Ratio | 24.73 | 47.07 | 24.59 | - | - | - |
PS Ratio | 2.78 | 3.46 | 2.70 | 3.20 | 3.05 | 3.83 |